Q2 2025 Novanta Inc Earnings Call Transcript

Aug 5, 2025 / 02:00 PM GMT

Release Date Price: $115.7 (-6.70%)

Transcript 10-Q8-K

Key Points

Positve

Novanta Inc (NOVT) delivered solid Q2 2025 results, meeting or exceeding expectations for sales, margins, and profit.
New product revenue grew by over 50% year over year, indicating strong innovation and market acceptance.
Customer orders increased by 10% year over year and 20% sequentially, reflecting a strengthening outlook.
The company announced two major design wins in the minimally invasive surgery market, showcasing its strong partnerships with leading OEMs.
Novanta Inc (NOVT) is on track to achieve $50 million of incremental new product revenue for 2025, driven by next-generation medical devices.

Negative

Revenue from industrial capital equipment declined year over year, affected by trade disruptions and customer demand, particularly in China.
The precision medicine business saw a 13% decline in sales year over year, impacted by weak end-market dynamics and funding cutbacks.
Operating cash flow for Q2 2025 was $15 million, down from $41 million in Q2 2024, primarily due to timing of tax payments and increased inventory purchases.
The impact of tariffs resulted in approximately a $4 million net impact on cost of sales year-to-date.
The semiconductor electronics market showed mixed signals, with some risk associated with new product shipments factored into the second half guidance.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NOVT.OQ - Novanta Inc
Q2 2025 Novanta Inc Earnings Call
Aug 05, 2025 / 02:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning. My name is Andrea and I will be your conference operator today.

At this time, I would like to welcome everyone to Novanta Incorporated 2nd quarter 2025 earnings call.

All lines have been placed on mute to prevent any background noise.

After the speaker's remarks there will be a question and answer session.

To ask a question, you may press star and one on your touchtone phone.

To withdraw your question, please press star then 2.

Please note this event is being recorded.

I would now like to turn the conference over to Ray Nash, corporate finance leader for Novanta. Please go ahead.

--------------------------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.